Intravenous immunoglobulin-mediated regulation of Notch ligands on human dendritic cells - 30/03/13
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
This study was supported by Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, Université Paris Descartes (to S.V.K. and J.B.), Centre National de la Recherche Scientifique (to S.V.K.), European Community’s Seventh Framework Programme (FP7/2007-2013, HEALTH-2010.2.4.5-2) under grant agreement HEALTH-No.: 260338 ALLFUN (to J.B.), Indian Institute of Science, Department of Biotechnology, Department of Science and Technology, Council for Scientific and Industrial Research (to K.N.B.), Coopération INSERM-ICMR-AO 2009/2010 (to K.N.B. and J.B.), and fellowships from INSERM-ICMR, Council for Scientific and Industrial Research (to J.T.). |
|
Disclosure of potential conflict of interest: J. Trinath has received grants from INSERM-ICMR, Council for Scientific and Industrial Research, Government of India. S. V. Kaveri has received grants from Talecris Biotherapeutics. K. Balaji has received grants from the Department of Biotechnology, Department of Science and Technology, Council for Scientific and Industrial Research, Government of India (Coopération INSERM-ICMR-AO 2009/2010). J. Bayry has received grants from the European Community’s Seventh Framework Programme (FP7/2007-2013, HEALTH-2010.2.4.5-2) under grant agreement HEALTH-No.: 260338 ALLFUN; Coopération INSERM-ICMR-AO 2009/2010; and Talecris Biotherapeutics. P. Hegde declares that she has no relevant conflicts of interest. |
Vol 131 - N° 4
P. 1255 - avril 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?